Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Liposuction Market

ID: MRFR/HC/16254-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US Liposuction Market Research Report Information By Procedure Type (Manual Liposuction, Ultrasound-Assisted Liposuction, Power-Assisted Liposuction, and Laser-Guided Liposuction), By Anatomy (Abdomen, Upper arms, Buttocks, Calves and ankles, Chest and back, Hips and thighs, and Chin and neck), By End User (Hospital Setting, Ambulatory Surgical Centres, and Plastic Surgery and Cosmetic Clinics) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Liposuction Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Abdominal Liposuction
  50.     4.1.2 Thigh Liposuction
  51.     4.1.3 Arm Liposuction
  52.     4.1.4 Back Liposuction
  53.     4.1.5 Neck Liposuction
  54.   4.2 Healthcare, BY Procedure Type (USD Billion)
  55.     4.2.1 Tumescent Liposuction
  56.     4.2.2 Ultrasound-Assisted Liposuction
  57.     4.2.3 Laser-Assisted Liposuction
  58.     4.2.4 Power-Assisted Liposuction
  59.     4.2.5 Suction-Assisted Liposuction
  60.   4.3 Healthcare, BY Gender (USD Billion)
  61.     4.3.1 Male
  62.     4.3.2 Female
  63.     4.3.3 Non-Binary
  64.   4.4 Healthcare, BY Age Group (USD Billion)
  65.     4.4.1 18-24 Years
  66.     4.4.2 25-34 Years
  67.     4.4.3 35-44 Years
  68.     4.4.4 45-54 Years
  69.     4.4.5 55 Years and Above
  70.   4.5 Healthcare, BY Body Mass Index Category (USD Billion)
  71.     4.5.1 Underweight
  72.     4.5.2 Normal Weight
  73.     4.5.3 Overweight
  74.     4.5.4 Obese
  75.     4.5.5 Morbidly Obese
  76. 5 SECTION V: COMPETITIVE ANALYSIS
  77.   5.1 Competitive Landscape
  78.     5.1.1 Overview
  79.     5.1.2 Competitive Analysis
  80.     5.1.3 Market share Analysis
  81.     5.1.4 Major Growth Strategy in the Healthcare
  82.     5.1.5 Competitive Benchmarking
  83.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  84.     5.1.7 Key developments and growth strategies
  85.       5.1.7.1 New Product Launch/Service Deployment
  86.       5.1.7.2 Merger & Acquisitions
  87.       5.1.7.3 Joint Ventures
  88.     5.1.8 Major Players Financial Matrix
  89.       5.1.8.1 Sales and Operating Income
  90.       5.1.8.2 Major Players R&D Expenditure. 2023
  91.   5.2 Company Profiles
  92.     5.2.1 Allergan (US)
  93.       5.2.1.1 Financial Overview
  94.       5.2.1.2 Products Offered
  95.       5.2.1.3 Key Developments
  96.       5.2.1.4 SWOT Analysis
  97.       5.2.1.5 Key Strategies
  98.     5.2.2 Merz North America (US)
  99.       5.2.2.1 Financial Overview
  100.       5.2.2.2 Products Offered
  101.       5.2.2.3 Key Developments
  102.       5.2.2.4 SWOT Analysis
  103.       5.2.2.5 Key Strategies
  104.     5.2.3 Hologic (US)
  105.       5.2.3.1 Financial Overview
  106.       5.2.3.2 Products Offered
  107.       5.2.3.3 Key Developments
  108.       5.2.3.4 SWOT Analysis
  109.       5.2.3.5 Key Strategies
  110.     5.2.4 Revance Therapeutics (US)
  111.       5.2.4.1 Financial Overview
  112.       5.2.4.2 Products Offered
  113.       5.2.4.3 Key Developments
  114.       5.2.4.4 SWOT Analysis
  115.       5.2.4.5 Key Strategies
  116.     5.2.5 Galderma (US)
  117.       5.2.5.1 Financial Overview
  118.       5.2.5.2 Products Offered
  119.       5.2.5.3 Key Developments
  120.       5.2.5.4 SWOT Analysis
  121.       5.2.5.5 Key Strategies
  122.     5.2.6 Sientra (US)
  123.       5.2.6.1 Financial Overview
  124.       5.2.6.2 Products Offered
  125.       5.2.6.3 Key Developments
  126.       5.2.6.4 SWOT Analysis
  127.       5.2.6.5 Key Strategies
  128.     5.2.7 InMode (US)
  129.       5.2.7.1 Financial Overview
  130.       5.2.7.2 Products Offered
  131.       5.2.7.3 Key Developments
  132.       5.2.7.4 SWOT Analysis
  133.       5.2.7.5 Key Strategies
  134.     5.2.8 Cynosure (US)
  135.       5.2.8.1 Financial Overview
  136.       5.2.8.2 Products Offered
  137.       5.2.8.3 Key Developments
  138.       5.2.8.4 SWOT Analysis
  139.       5.2.8.5 Key Strategies
  140.     5.2.9 Apyx Medical (US)
  141.       5.2.9.1 Financial Overview
  142.       5.2.9.2 Products Offered
  143.       5.2.9.3 Key Developments
  144.       5.2.9.4 SWOT Analysis
  145.       5.2.9.5 Key Strategies
  146.   5.3 Appendix
  147.     5.3.1 References
  148.     5.3.2 Related Reports
  149. 6 LIST OF FIGURES
  150.   6.1 MARKET SYNOPSIS
  151.   6.2 US MARKET ANALYSIS BY APPLICATION
  152.   6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
  153.   6.4 US MARKET ANALYSIS BY GENDER
  154.   6.5 US MARKET ANALYSIS BY AGE GROUP
  155.   6.6 US MARKET ANALYSIS BY BODY MASS INDEX CATEGORY
  156.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  157.   6.8 RESEARCH PROCESS OF MRFR
  158.   6.9 DRO ANALYSIS OF HEALTHCARE
  159.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  160.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  161.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  162.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  163.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  164.   6.15 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
  165.   6.16 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
  166.   6.17 HEALTHCARE, BY GENDER, 2024 (% SHARE)
  167.   6.18 HEALTHCARE, BY GENDER, 2024 TO 2035 (USD Billion)
  168.   6.19 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
  169.   6.20 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
  170.   6.21 HEALTHCARE, BY BODY MASS INDEX CATEGORY, 2024 (% SHARE)
  171.   6.22 HEALTHCARE, BY BODY MASS INDEX CATEGORY, 2024 TO 2035 (USD Billion)
  172.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  173. 7 LIST OF TABLES
  174.   7.1 LIST OF ASSUMPTIONS
  175.     7.1.1
  176.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  177.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  178.     7.2.2 BY PROCEDURE TYPE, 2026-2035 (USD Billion)
  179.     7.2.3 BY GENDER, 2026-2035 (USD Billion)
  180.     7.2.4 BY AGE GROUP, 2026-2035 (USD Billion)
  181.     7.2.5 BY BODY MASS INDEX CATEGORY, 2026-2035 (USD Billion)
  182.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  183.     7.3.1
  184.   7.4 ACQUISITION/PARTNERSHIP
  185.     7.4.1

US Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Abdominal Liposuction
  • Thigh Liposuction
  • Arm Liposuction
  • Back Liposuction
  • Neck Liposuction

Healthcare By Procedure Type (USD Billion, 2026-2035)

  • Tumescent Liposuction
  • Ultrasound-Assisted Liposuction
  • Laser-Assisted Liposuction
  • Power-Assisted Liposuction
  • Suction-Assisted Liposuction

Healthcare By Gender (USD Billion, 2026-2035)

  • Male
  • Female
  • Non-Binary

Healthcare By Age Group (USD Billion, 2026-2035)

  • 18-24 Years
  • 25-34 Years
  • 35-44 Years
  • 45-54 Years
  • 55 Years and Above

Healthcare By Body Mass Index Category (USD Billion, 2026-2035)

  • Underweight
  • Normal Weight
  • Overweight
  • Obese
  • Morbidly Obese

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓